Mannkind reported $5.98M in Gross Profit on Sales for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Gross Profit On Sales Change
Biocryst Pharmaceuticals BCRX:US $ 65.28M 15.6M
ChemoCentryx CCXI:US 10.96M 5.71M
Dynavax Technologies DVAX:US $ 173.1M 99.06M
Eli Lilly And LLY:US $ 5057.5M 680.4M
Halozyme Therapeutics HALO:US $ 118.42M 17.07M
Insmed INSM:US $ 48.83M 7.91M
JAZZ PHA JAZZ:US $ 808.67M 110.23M
Karyopharm Therapeutics KPTI:US $ 38.74M 7.5M
MacroGenics MGNX:US 23.6M 12.55M
Mannkind MNKD:US $ 5.98M 4.99M
Merk MRK:US $ 10895M 328M
Novo Nordisk A Fs NVO:US $ 35196M 82M
Peregrine Pharmaceuticals PPHM:US $ 9.12M 2.13M
Pfizer PFE:US $ 19071M 3420M